1 / 4Morgan Stanley on Cholamandalam Investment and Finance Company | The brokerage firm said that the company has posted better-than-expected disbursements in Q4 and collection efficiency was strong at 138 percent. It has an 'equal-weight' stance on the stock.
2 / 4Morgan Stanley on Macrotech Developers | The brokerage firm has an 'equal-weight' rating on shares of Macrotech Developers with a target price of Rs 1,298.
3 / 4Credit Suisse on Titan | The brokerage firm has maintained its 'neutral' rating on shares of Titan with a target price of Rs 2,750. Growth has tended to be resilient even through periods of stress, Credit Suisse noted.
4 / 4Jefferies on Cholamandalam Investment | Increasing collection efficiency should lead to better asset quality QoQ, said Jefferies while maintaining its 'buy' call on the stock.
